Institute of Biomedical Research Corp. (MRES)
OTCMKTS · Delayed Price · Currency is USD
0.0009
0.00 (-4.26%)
Jul 6, 2026, 9:46 AM EST
MRES Market Cap
MRES has a market cap or net worth of $2.58 million as of July 6, 2026. Its market cap has decreased by -90.67% in one year.
Market Cap
2.58M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since March 31, 2016, MRES's market cap has increased from 693.95K to 2.58M, an increase of 272.41%. That is a compound annual growth rate of 13.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2026 | 2.58M | -66.43% |
| Dec 31, 2025 | 7.70M | -83.96% |
| Dec 31, 2024 | 47.98M | 138.03% |
| Dec 29, 2023 | 20.16M | 17.54% |
| Dec 30, 2022 | 17.15M | 149.69% |
| Dec 31, 2021 | 6.87M | 971.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CASI Pharmaceuticals | 3.02M |
| Bioxytran | 2.85M |
| Vaccinex | 2.73M |
| Iterum Therapeutics | 2.64M |
| AccuStem Sciences | 2.51M |
| Hepion Pharmaceuticals | 2.44M |
| Bio-Path Holdings | 2.36M |
| VitaSpring Biomedical | 2.30M |